Inclusion Criteria:  Women older than 18 years of age Breast cancer with treatment plan that includes doxorubicin and/or trastuzumab Ability to provide written informed consent  Exclusion Criteria:  Pregnancy at enrollment Inability or unwillingness to provide consent